These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5529422)

  • 21. [Activation of P32-incorporation into nucleotides of thymus nuclei by bases and ribonucleosides].
    Dancheva KI
    Vopr Med Khim; 1970; 16(1):38-42. PubMed ID: 5435385
    [No Abstract]   [Full Text] [Related]  

  • 22. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine.
    Tidd DM; Paterson AR
    Cancer Res; 1974 Apr; 34(4):738-46. PubMed ID: 4856046
    [No Abstract]   [Full Text] [Related]  

  • 23. Formal discussion: future prospects in leukemia chemotherapy.
    Modest EJ
    Cancer Res; 1965 Oct; 25(9):1649-51. PubMed ID: 4221941
    [No Abstract]   [Full Text] [Related]  

  • 24. Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine.
    Tidd DM; Paterson AR
    Cancer Res; 1974 Apr; 34(4):733-7. PubMed ID: 4856045
    [No Abstract]   [Full Text] [Related]  

  • 25. Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent.
    Podsiadlo P; Sinani VA; Bahng JH; Kam NW; Lee J; Kotov NA
    Langmuir; 2008 Jan; 24(2):568-74. PubMed ID: 18052300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of antibody production by thioinosine. 3. Studies on antibody biosynthesis.
    Ogata M; Kumashiro K
    Acta Med Okayama (1952); 1970 Jun; 24(3):311-4. PubMed ID: 4249887
    [No Abstract]   [Full Text] [Related]  

  • 27. Historical background of 6-mercaptopurine.
    Elion GB
    Toxicol Ind Health; 1986 Sep; 2(2):1-9. PubMed ID: 3538499
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the antitumor activity of 6-mercaptopurine riboside. II.
    Nakai Y; Sato K; Kurita K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):99-105. PubMed ID: 5525313
    [No Abstract]   [Full Text] [Related]  

  • 29. Further studies on the metabolic effects of 9-beta-D-arabinofuranosyl-9-H-purine-6-thiol.
    Kimball AP; LePage GA; Allinson PS
    Cancer Res; 1967 Jan; 27(1):106-16. PubMed ID: 6066998
    [No Abstract]   [Full Text] [Related]  

  • 30. Decreased feedback inhibition in a 6-(methylmercapto)purine ribonucleoside-resistant tumor.
    Henderson JF; Caldwell IC; Paterson AR
    Cancer Res; 1967 Oct; 27(10):1773-8. PubMed ID: 6064956
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the antitumor activity of 6-merceptopurine riboside. I.
    Sato K; Nakai Y; Kurita K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):92-8. PubMed ID: 5525312
    [No Abstract]   [Full Text] [Related]  

  • 32. Purine metabolism in the chick embryo; effects of uricogenesis and xanthine oxidase inhibition.
    Duggan DE; Pua KH; Elfenbein G
    Mol Pharmacol; 1968 Jan; 4(1):53-60. PubMed ID: 5640779
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
    Damaraju D; Damaraju VL; Brun M; Mowles D; Kuzma M; Berendt RC; Sawyer MB; Cass CE
    Biochem Pharmacol; 2008 May; 75(10):1901-11. PubMed ID: 18371936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
    Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of structure of purine and pyrimidine nucleosides to antitumor activity.
    Goldin A; Wood HB; Engle RR
    Cancer Chemother Rep 2; 1968 Oct; 1(1):1-272. PubMed ID: 5743752
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and biological activity of certain 8-mercaptopurine and 6-mercaptopyrimidine S-nucleosides.
    Shuman DA; Bloch A; Robins RK; Robins MJ
    J Med Chem; 1969 Jul; 12(4):653-7. PubMed ID: 4893463
    [No Abstract]   [Full Text] [Related]  

  • 37. EFFECT OF 6-MERCAPTOPURINE RIBOSIDE (NSC-4911) IN 41 ADULT PATIENTS WITH ACUTE LEUKEMIA.
    WHITTINGTON RM; RIVERS SL; PATNO ME
    Cancer Chemother Rep; 1964 Jan; 34():47-50. PubMed ID: 14116218
    [No Abstract]   [Full Text] [Related]  

  • 38. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
    Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
    Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic studies with carbocyclic analogs of purine nucleosides.
    Bennett LL; Allan PW; Hill DL
    Mol Pharmacol; 1968 May; 4(3):208-17. PubMed ID: 5661770
    [No Abstract]   [Full Text] [Related]  

  • 40. [Considerations on therapy of 56 cases of leukemia in childhood].
    Zilocchi C
    Minerva Pediatr; 1966 Jun; 18(19):991-3. PubMed ID: 5947982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.